MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI MyeloMATCH Clinical Trials

Sponsor:

SWOG

Sponsor Study ID:

MyeloMATCH

CTO #:

104219

NCT Number:

NCT05564390

Phase:

N/A

Protocol Type:

Screening

Age Group:

Adults

Disease Sites:

Myeloid and Monocytic Leukemia; Other Hematopoietic

Study Objectives:

To evaluate the feasibility of MATCHBox organizing all specimen testing results needed for assignment to a myeloMATCH clinical trial or Tier Advancement Pathway (TAP) within one hor prior to the first Treatment Verfication Cell had 4 days after MDNet receipt of all required specimens for initial therapy and within 11 days for subsequent therapies.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)